HKSE - Delayed Quote ? HKD
Shanghai Henlius Biotech, Inc. (2696.HK)
As of 11:56 AM GMT+8. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
9,903,571.000
8,924,308.000
7,172,844.000
6,439,176.000
--
Total Liabilities Net Minority Interest
7,711,270.000
7,287,976.000
4,876,088.000
3,240,404.000
--
Total Equity Gross Minority Interest
2,192,301.000
1,636,332.000
2,296,756.000
3,198,772.000
--
Total Capitalization
3,298,520.000
2,611,625.000
3,130,456.000
3,622,969.000
--
Common Stock Equity
2,192,301.000
1,636,332.000
2,296,756.000
3,198,772.000
--
Capital Lease Obligations
273,416.000
261,092.000
292,750.000
292,975.000
--
Net Tangible Assets
-2,318,428.000
-2,695,951.000
-1,338,175.000
256,318.000
--
Working Capital
-2,391,401.000
-2,810,036.000
-1,312,566.000
-69,514.000
--
Invested Capital
6,011,936.000
5,052,335.000
4,626,943.000
4,739,414.000
--
Tangible Book Value
-2,318,428.000
-2,695,951.000
-1,338,175.000
256,318.000
--
Total Debt
4,093,051.000
3,677,095.000
2,622,937.000
1,833,617.000
--
Net Debt
2,831,970.000
2,735,525.000
2,175,205.000
426,333.000
--
Share Issued
543,494.853
543,494.853
543,494.853
543,494.853
--
Ordinary Shares Number
543,494.853
543,494.853
543,494.853
543,494.853
--
12/31/2019 - 9/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBDA.BE Protalix BioTherapeutics Inc
0.9674
-4.12%
PHBBF Pharmaron Beijing Co., Ltd.
1.9300
0.00%
688180.SS Shanghai Junshi Biosciences Co., Ltd.
23.83
+2.98%
6160.HK BeiGene, Ltd.
122.200
+0.08%
9969.HK InnoCare Pharma Limited
5.310
-2.93%
2142.HK HBM Holdings Limited
1.200
-1.64%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
165.800
-4.71%
2315.HK Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
5.970
-4.63%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.340
+3.08%
1801.HK Innovent Biologics, Inc.
41.200
-1.44%